Plasticell is a privately held biotechnology company using novel cell culture and drug discovery platforms to produce regenerative small molecule drugs.
Plasticell aims to develop drugs by elucidating
the biochemical mechanisms that control the proliferation and differentiation
of stem cells, the master cells responsible for tissue development
and repair.
Plasticell also forms alliances with industry
partners to produce high value cell lines for drug discovery research
and cell therapy applications.
